Observing the use of Ziconotide for treating severe chronic pain

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the use of Ziconotide, a potent analgesic administered via intrathecal injection, for patients suffering from refractory chronic pain. The study aims to gather data on its effectiveness and safety in clinical practice, particularly regarding the management of neuropsychiatric adverse reactions associated with its use. By analyzing real-world outcomes, the study seeks to enhance understanding of optimal dosing and administration practices for Ziconotide. The findings could help refine treatment protocols and improve patient care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years old
* Severe refractory chronic pain requiring intrathecal analgesia
* Candidate for intrathecal analgesia treatment with ziconotide
* Patient informed about the study and agreeing to take part in.

Exclusion Criteria:

* Contraindications to ziconotide

Where it's running

• University of Freiburg
  Freiburg im Breisgau, Germany Recruiting
• Justus-Liebig-Universitat
  Giessen, Germany Recruiting
• Jena University Hospital
  Jena, Germany Recruiting
• Hospital Universitario Puerta Del Mar
  Cadiz, Spain Recruiting
• Hospital General Universitario Santa Lucía
  Cartagena, Spain Recruiting
• Hospital Universitario Virgen de las Nieves
  Granada, Spain Recruiting

Study contacts

• Study coordinator: Denis Dupoiron, Md
• Email: denis.dupoiron@ico.unicancer.fr
• Phone: +33 241352700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing two types of radiofrequency treatments for trigeminal neuralgia pain

  This study is testing which type of radiofrequency treatment, bipolar or monopolar, works better for relieving pain in people with trigeminal neuralgia who haven't found relief from other medications.

  Recruiting at 2 sites Alexandria University · Alexandria and 1 other locations · NCT06779578

• Intrathecal drug delivery vs standard care for severe cancer pain

  This trial tests whether delivering pain medicine directly into the spinal fluid helps people with severe cancer pain experience better relief than usual oral medications.

  Recruiting Universitair Ziekenhuis Brussel · Jette · NCT07691840

• Hydromorphone plus electroacupuncture and ear acupressure for refractory cancer pain

  This trial tests whether adding electroacupuncture and ear acupressure to hydromorphone extended-release tablets helps relieve refractory cancer pain.

  Recruiting Early Phase 1 Qinghai Red Cross Hospital · Xining · NCT07489625

• Lidocaine and Ketamine for opioid-refractory cancer pain

  This randomized, double-blind, cross-over study tests whether two weekly infusions of lidocaine and low-dose ketamine reduce pain more than an active placebo in adults with cancer-related pain not controlled by opioids.

  Recruiting Early Phase 1 National and Kapodistrian University of Athens · Athens, Attica · NCT07408193

• TENS for endometriosis-related pelvic pain

  This study tests whether two types of TENS (conventional and microstimulation) can reduce chronic pelvic pain in adults with endometriosis or adenomyosis who are on stable hormone therapy.

  Recruiting Monath Electronic · Bordeaux · NCT07393295

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.